Byeong-Gu Kim

Hucord Co., Ltd. is a biotechnology company engaged in human cell-based therapy. It develops stem cell technology along with the cord blood, specializing in Multi-Lineage Progenitor Cells (MLPCs) research, treatment of disease and banking of cells. The group works in the following divisions: cord blood banking, stem cell banking, stem cell research and development, stem cell therapy management and the immunogenetics laboratory. It also performs the Human leukocyte antigen typing method which determines the compatibility of tissues between patient and the donor. The company was founded on January 24, 1979 and is headquartered in Yongin-si, South Korea.